Home About us Current issue Ahead of Print Back issues Submission Instructions Advertise Contact Login   

Search Article 
  
Advanced search 
 
Saudi Journal of Kidney Diseases and Transplantation
Users online: 231 Home Bookmark this page Print this page Email this page Small font sizeDefault font size Increase font size 
This article has been cited by
1Rituximab bei primärer FSGS und MCD im Erwachsenenalter
A. Kronbichler,M. Rudnicki,G. Mayer
Der Nephrologe.2013;8(2)144
[DOI]
2Podocytes from the diagnostic and therapeutic point of view
Janina Müller-Deile,Mario Schiffer
Pflügers Archiv - European Journal of Physiology.2017;469(7-8)1007
[DOI]
3Experience of application of rituximab with resistant focal-segmental glomerulosclerosis in adults: a series of observations and a brief review of literature
N. V. Chebotareva,A. M. Kuchieva,O. A. Lee,C. V. Roshchupkina,V. Cao
Nephrology (Saint-Petersburg).2020;24(2)52
[DOI]
4Advanced therapeutics in focal and segmental glomerulosclerosis
Yunzi Liu,Yifan Shi,Rong Ren,Jingyuan Xie,Weiming Wang,Nan Chen
Nephrology.2018;23(2)57
[DOI]
5Single dose of rituximab in children with steroid-dependent minimal change nephrotic syndrome
Xiao-Ling Niu,Sheng Hao,Ping Wang,Wei Zhang,Gui-Mei Guo,Ying Wu,Xin-Yu Kuang,Guang-Hua Zhu,Wen-Yan Huang
Biomedical Reports.2016;5(2)237
[DOI]
6Rituximab Treatment for Relapsing Minimal Change Disease and Focal Segmental Glomerulosclerosis: A Systematic Review
Andreas Kronbichler,Julia Kerschbaum,Gema Fernandez-Fresnedo,Elion Hoxha,Christine E. Kurschat,Martin Busch,Annette Bruchfeld,Gert Mayer,Michael Rudnicki
American Journal of Nephrology.2014;39(4)322
[DOI]
7Rituximab treatment in adults with refractory minimal change disease or focal segmental glomerulosclerosis
Hong Ren,Li Lin,Pingyan Shen,Xiao Li,Jingyuan Xie,Xiaoxia Pan,Wen Zhang,Nan Chen
Oncotarget.2017;8(55)93438
[DOI]
  My Preferences